...
首页> 外文期刊>Journal of Clinical Microbiology >Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection.
【24h】

Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection.

机译:通过酶免疫测定在患有原发性巨细胞病毒感染的移植接受者中检测到的人类疱疹病毒6抗体升高。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Immunoglobulin G to human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) in sera from solid organ recipients was measured by an enzyme-linked immunoassay (ELISA) before and after transplant. The HHV-6 ELISA was developed from glycine extracts of HHV-6-infected and uninfected HSB-2 cells. At a serum dilution of 1:500, 80 (91%) of 88 recipients were seropositive for HHV-6 before transplant, while only 14 (16%) were seropositive for CMV. Posttransplant HHV-6 serologic rises were observed in 38 (43%) recipients; rises in 25 of these recipients were associated with primary CMV infection. Titration of sera revealed much higher HHV-6 titer rises among those with primary CMV infection than among those with CMV reactivation or with no CMV infection. Elevated HHV-6 antibody titers persisted for up to 2 years after primary CMV infection. No correlation was noted between CMV and HHV-6 antibody titers in individual serum samples.
机译:在移植之前和之后,通过酶联免疫测定(ELISA)测量来自实体器官受体血清中人疱疹病毒6(HHV-6)和巨细胞病毒(CMV)的免疫球蛋白G。 HHV-6 ELISA是从感染HHV-6和未感染HSB-2细胞的甘氨酸提取物中开发的。在1:500的血清稀释度下,在移植前88位接受者中有80位(91%)对HHV-6呈血清阳性,而CMV仅14位(16%)对SHV呈血清阳性。 38名(43%)接受者观察到移植后HHV-6血清学升高;这些接受者中有25人的上升与原发性巨细胞病毒感染有关。血清滴定显示,原发性巨细胞病毒感染者的血清HHV-6滴度要比具有巨细胞病毒重新激活或无巨细胞病毒感染者高。初次CMV感染后,升高的HHV-6抗体滴度持续长达2年。在各个血清样品中,CMV和HHV-6抗体滴度之间没有相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号